reboxetine has been researched along with Weight Gain in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, SM; Ahsan, ZA; Cohn, T; Duncan, MJ; Faulkner, GEJ; Hahn, M; Lockwood, JT; Remington, G; Stogios, N; Takeuchi, H; Taylor, VH | 1 |
| Amrami-Weizman, A; Fuchs, C; Gil-Ad, I; Kotler, M; Maayan, R; Pashinian, A; Poyurovsky, M | 1 |
| First, M; Gil-Ad, I; Novak, N; Taler, M; Tarasenko, I; Weizman, A | 1 |
| Fuchs, C; Levi, A; Pashinian, A; Poyurovsky, M; Weizman, A; Weizman, R | 1 |
| Faragian, S; Fuchs, C; Isaacs, I; Poyurovsky, M; Schneidman, M; Weizman, A; Weizman, R | 1 |
| Faragian, S; Fuchs, C; Gil-Ad, I; Levi, A; Maayan, R; Pashinian, A; Poyurovsky, M | 1 |
1 review(s) available for reboxetine and Weight Gain
| Article | Year |
|---|---|
Pharmacological interventions for prevention of weight gain in people with schizophrenia.
Topics: Antipsychotic Agents; Betahistine; Famotidine; Fluoxetine; Humans; Melatonin; Metformin; Nausea; Nizatidine; Ranitidine; Reboxetine; Schizophrenia; Topiramate; Weight Gain | 2022 |
4 trial(s) available for reboxetine and Weight Gain
| Article | Year |
|---|---|
The effect of reboxetine co-administration with olanzapine on metabolic and endocrine profile in schizophrenia patients.
Topics: Adrenergic Uptake Inhibitors; Adult; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Morpholines; Olanzapine; Reboxetine; Schizophrenia; Weight Gain; Young Adult | 2013 |
Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine-betahistine combination.
Topics: Adrenergic Uptake Inhibitors; Adult; Antipsychotic Agents; Benzodiazepines; Betahistine; Double-Blind Method; Female; Histamine Agonists; Humans; Male; Middle Aged; Morpholines; Olanzapine; Reboxetine; Schizophrenia; Treatment Outcome; Weight Gain; Young Adult | 2013 |
Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study.
Topics: Adrenergic Uptake Inhibitors; Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Morpholines; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Reboxetine; Schizophrenia; Treatment Outcome; Weight Gain | 2003 |
Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study.
Topics: Adrenergic Uptake Inhibitors; Adult; Antipsychotic Agents; Appetite; Benzodiazepines; Body Mass Index; Double-Blind Method; Female; Humans; Male; Middle Aged; Morpholines; Olanzapine; Reboxetine; Schizophrenia; Weight Gain | 2007 |
1 other study(ies) available for reboxetine and Weight Gain
| Article | Year |
|---|---|
The effects of reboxetine treatment on depression-like behavior, brain neurotrophins, and ERK expression in rats exposed to chronic mild stress.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Brain; Brain-Derived Neurotrophic Factor; Depressive Disorder; Dietary Sucrose; Extracellular Signal-Regulated MAP Kinases; Food Preferences; Gene Expression; Male; Maze Learning; Morpholines; Phosphorylation; Rats; Rats, Sprague-Dawley; Reboxetine; Receptor, trkB; Stress, Psychological; Weight Gain | 2013 |